Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Akroswiss Logo
Akroswiss Growth Score
65
CB Rank
133483
Heat Score
52
Akroswiss develops and commercializes intranasal midazolam therapies and bi-dose delivery devices for seizure treatment and sedation.
Founded
obfuscation
PrivateSeed Zug, Zug, Switzerland1-10 www.akroswiss.ch/
Biotechnology
Pharmaceutical